Case Series Volume 15 Issue 11 - 2026

Beyond the Ground-Glass Opacity: Diagnostic Mimics of COVID-19 Pneumonia—A Three-Case Series

Trilok Chand1*and Samah Beltagy2

1Consultant and Head Pulmonologist, Burjeel Hospital, Abu Dhabi, United Arab Emirates
2Consultant Pulmonologist, Burjeel Medical Center, Al Shamkha, United Arab Emirates

*Corresponding Author: Trilok Chand, Consultant and Head Pulmonologist, Burjeel Hospital, Abu Dhabi, United Arab Emirates.
Received: October 21, 2026; Published: October 28, 2026



Coronavirus disease 2019 (COVID-19) commonly produces non-specific respiratory symptoms and chest computed tomography (CT) abnormalities that can overlap with non-infectious disorders. We describe three patients whose clinical and radiological presentations initially suggested COVID-19 pneumonia but whose severe acute respiratory syndrome coronavirus 2 testing was negative. A 53-year-old woman with rheumatoid arthritis had multifocal bilateral consolidation and ground-glass change; bronchoscopic cryo biopsy showed organising pneumonia, and the abnormalities resolved with prednisolone. A 19-year-old man had bilateral ground-glass opacities, marked peripheral eosinophilia, and bronchoscopic lavage with 50% eosinophils, supporting idiopathic eosinophilic pneumonia; he improved after prednisolone. A 68-year-old man with fever and haemoptysis had bilateral nodular and ground-glass changes; echocardiography revealed severe mitral valve prolapse with chordal rupture and significant mitral regurgitation. These cases demonstrate that COVID-19-like imaging is not specific and that persistent test negativity should prompt careful evaluation for alternative inflammatory, eosinophilic, and cardiogenic causes.

Keywords: COVID-19 Pneumonia; COVID-19 Mimics; Pulmonary Eosinophilia; Cryptogenic Organising Pneumonia; Mitral Valve Regurgitation; Cryo Lung Biopsy

  1. Stokes E K., et al. “Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020”. MMWR Morbidity and Mortality Weekly Report24 (2020): 759-765. 
  2. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. The Lancet10223 (2020): 497-506. 
  3. Wang D., et al. “Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China”. JAMA11 (2020): 1061-1069. 
  4. Richardson S., et al. “Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area”. JAMA20 (2020): 2052-2059. 
  5. Kanne J P., et al. “COVID-19 Imaging: What We Know Now and What Remains Unknown”. Radiology3 (2021): E262-E279. 
  6. Woloshin S., et al. “False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications”. New England Journal of Medicine6 (2020): e38. 
  7. Drakopanagiotakis F., et al. “Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis”. Chest4 (2011): 893-900. 
  8. Allen J N. and Davis W B. “Eosinophilic lung diseases”. American Journal of Respiratory and Critical Care Medicine5 Pt 1 (1994): 1423-1438. 
  9. Inotani S., et al. “Unilateral cardiogenic pulmonary edema”. Journal of Cardiology Cases3 (2018): 85-88. 
  10. Horowitz H W., et al. “COVID-19 and the Consequences of Anchoring Bias”. Emerging Infectious Diseases8 (2021): 2235-2236. 

Trilok Chand and Samah Beltagy. “Beyond the Ground-Glass Opacity: Diagnostic Mimics of COVID-19 Pneumonia—A Three-Case Series”. EC Pulmonology and Respiratory Medicine 15.11 (2026): 01-07.